In October 2014, the U.S. Drug Enforcement Administration rescheduled all hydrocodone combination products from schedule C-III controlled substances to C-II controlled substances. C-II controlled substances require new prescriptions at intervals no greater than 30 days, though a practitioner may issue up to three consecutive prescriptions in one visit (essentially authorizing the patient to receive a […]
Have a legal question? Send us an email today!
Archive | December, 2014
CMS Issues Notice of Hydrocodone Combination Product Coverage Changes for WCMSA Proposals Submitted on or after January 1, 2015
Read full story • Comments are closed